Affimed Therapeutics
A company developing immunotherapies for the treatment of cancer
1
Funding Rounds
$26.5m
Money raised
Overview
A company developing immunotherapies for the treatment of cancer
-
Website:
- Business model: B2B
- Social accounts:
Funding series
Funding Series Analysis
The company Affimed Therapeutics has raised a total of $26.51m in funding over 1 rounds.
Key Insights:
- Affimed Therapeutics Series C round: $26.51m
Affimed Therapeutics Series C round
$26.51m
Industries
Affimed Therapeutics is active in the following industries: